Abstract
Neurological long-term sequelae are increasingly considered an important challenge in the recent COVID-19 pandemic. However, most evidence for neurological symptoms after SARS-CoV-2 infection and central nervous system invasion of the virus stems from individuals severely affected in the acute phase of the disease. Here, we report long-lasting cognitive impairment along with persistent cerebrospinal fluid anti-SARS-CoV-2 antibodies in a female patient with unremarkable standard examination 6 months after mild COVID-19, supporting the implementation of neuropsychological testing and specific cerebrospinal fluid investigation also in patients with a relatively mild acute disease phase.
Originalsprache | Englisch |
---|---|
Zeitschrift | Neurological research and practice |
Jahrgang | 3 |
Ausgabenummer | 1 |
Seiten (von - bis) | 34 |
ISSN | 2524-3489 |
DOIs | |
Publikationsstatus | Veröffentlicht - 21.06.2021 |
Strategische Forschungsbereiche und Zentren
- Querschnittsbereich: Medizinische Genetik
- Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)
DFG-Fachsystematik
- 2.23-07 Klinische Neurologie, Neurochirurgie und Neuroradiologie
- 2.22-13 Pneumologie, Thoraxchirurgie
- 2.21-05 Immunologie
- 2.21-04 Virologie
Coronavirus-Bezug
- Forschung zu SARS-CoV-2 / COVID-19